Keryx Biopharmaceuticals to Host Conference Call of Third Quarter 2017 Financial Results on Monday, November 6, 2017
October 26 2017 - 4:15PM
Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical
company focused on bringing innovative medicines to people with
kidney disease, today announced that it plans to host a conference
call and webcast on Monday, November 6, 2017 at 5:00 p.m. ET to
discuss its third quarter 2017 financial results and provide a
corporate update.
To participate in the conference call, please dial
1-888-396-2320 (U.S.), 1-774-264-7560 (international) and refer to
conference ID: 2193619. The call will be webcast live with slides
and accessible through the Investors section of the company’s
website at www.keryx.com for a period of 15 days after the
call.
About Keryx Biopharmaceuticals,
Inc.Keryx Biopharmaceuticals, Inc., with headquarters in
Boston, Massachusetts, is focused on the development and
commercialization of innovative medicines that provide unique and
meaningful advantages to people with kidney disease. The Keryx team
consists of approximately 200 committed people working with passion
to advance the care of people with this complex disease. In
September 2014, the U.S. Food and Drug Administration approved
Keryx’s first medicine, Auryxia® (ferric citrate) tablets. For more
information about Keryx, please visit www.keryx.com.
Keryx Biopharmaceuticals
Contacts:
Amy SullivanSVP, Corporate AffairsT:
617-466-3519Amy.sullivan@keryx.com
Lora PikeSenior Director, Investor Relations &
Corporate CommunicationsT: 617.466.3511lora.pike@keryx.com
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart
From Apr 2023 to Apr 2024